| A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to research led by scientists from The University of Texas MD Anderson … Continue reading |
|
The post Advanced melanoma vaccine improves response rate, survival: first cancer vaccine to show an improved response rate in patients: NEJM appeared first on Health, Medical, and Science Updates.